Paul Bresge

Founder & CEO

Co-founder and CEO of Ray Therapeutics. Entered ophthalmologic gene therapy in 2010 after his daughter was diagnosed with retinitis pigmentosa. Previously CEO of jCyte Inc. which landed a $252M licensing deal with Santen Pharmaceutical. BA from York University.

Overview

Companies
1
Roles
Founder & CEO

Companies

1 company
Ray Therapeutics $231M
Private Founder & CEO

Founder data is compiled from company records, public announcements, and verified sources. Roles reflect current or most recent known positions.